M-525
M-525 is a first-in-class, highly potent, irreversible and covalent menin-MLL protein-protein interaction inhibitor. M-525 binds to menin with an IC50 of 3 nM and achieves low nanomolar potencies in cell growth inhibition and in suppression of MLL regulated gene expression in MLL leukemia cells. Anti-leukemia activity.
For research use only. We do not sell to patients.
- CAS No.: 2173582-08-4
- Formula: C39H51FN6O5S
- Molecular Weight:734.92
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HL-60 | GI50 |
0.9 μM
Compound: 9; M-525
|
Anticancer activity against human HL-60 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human HL-60 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| HL-60 | IC50 |
1500 nM
Compound: M-525
|
Growth inhibition of human HL60 cells after 7 days by WST-8 assay
Growth inhibition of human HL60 cells after 7 days by WST-8 assay
|
[PMID: 32338903] |
| K562 | GI50 |
0.9 μM
Compound: 9; M-525
|
Anticancer activity against human K562 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human K562 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| MOLM-13 | GI50 |
15.4 nM
Compound: 15; M-525
|
Antiproliferative activity against human MOLM-13 cells
Antiproliferative activity against human MOLM-13 cells
|
[PMID: 34726905] |
| MOLM-13 | GI50 |
2.3 nM
Compound: 9; M-525
|
Anticancer activity against human MOLM-13 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human MOLM-13 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| MOLM-13 | IC50 |
19 nM
Compound: M-525
|
Growth inhibition of human MOLM13 cells after 7 days by WST-8 assay
Growth inhibition of human MOLM13 cells after 7 days by WST-8 assay
|
[PMID: 32338903] |
| MOLM-14 | GI50 |
2.3 nM
Compound: 9; M-525
|
Anticancer activity against human MOLM-14 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human MOLM-14 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| MOLM-16 | GI50 |
0.9 μM
Compound: 9; M-525
|
Anticancer activity against human MOLM16 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human MOLM16 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| MONO-MAC-6 | GI50 |
2.3 nM
Compound: 9; M-525
|
Anticancer activity against human MONO-MAC-6 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human MONO-MAC-6 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| MV4-11 | GI50 |
2.3 nM
Compound: 9; M-525
|
Anticancer activity against human MV4-11 cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human MV4-11 cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| MV4-11 | GI50 |
2.7 nM
Compound: 15; M-525
|
Antiproliferative activity against human MV4-11 cells
Antiproliferative activity against human MV4-11 cells
|
[PMID: 34726905] |
| MV4-11 | IC50 |
4 nM
Compound: M-525
|
Growth inhibition of human MV4-11 cells after 7 days by WST-8 assay
Growth inhibition of human MV4-11 cells after 7 days by WST-8 assay
|
[PMID: 32338903] |
| RS4-11 | GI50 |
2.3 nM
Compound: 9; M-525
|
Anticancer activity against human RS4-11 cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human RS4-11 cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| SEM | GI50 |
2.3 nM
Compound: 9; M-525
|
Anticancer activity against human SEM cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human SEM cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
| SKM-1 | GI50 |
0.9 μM
Compound: 9; M-525
|
Anticancer activity against human SKM-1 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay
Anticancer activity against human SKM-1 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay
|
[PMID: 36528996] |
M-525 achieves an IC50 of 3 nM in the MV4;11 cell line and has an IC50 of 2 µM in the HL-60 cell line. M-525 (3-300 nM; 24 h) is potent and effective in suppressing the expression of MEIS1 and HOX genes in MV4;11 cells carrying the MLL-AF4 fusion and in MOLM-13 cells carrying the MLL-AF9 fusion. It demonstrates high cellular specificity over non-MLL leukemia cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2173582-08-4
-
Molecular Weight 734.92
-
Formula C39H51FN6O5S
-
SMILES
O=C(OC)N[C@@H]1[C@@H]([C@](C2CCN(CC3CN(C4=CC=C(S(=O)(C5CN(C(/C=C/CN(C)C)=O)C5)=O)C=C4)C3)CC2)(C#N)C6=CC=CC(F)=C6)CCC1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)